Boehringer Ingelheim and the Lower Franconian company EMFRET Analytics want to advance an active substance for the treatment of strokes. Its roots lie in the Würzburg University Medicine.
moreBelow you can find press releases and news of the Rudolf Virchow Center.
Are you searching for a specific press release? Please take a look at our archive as well.
Boehringer Ingelheim and the Lower Franconian company EMFRET Analytics want to advance an active substance for the treatment of strokes. Its roots lie in the Würzburg University Medicine.
more
A lack of vitamin B2 makes tumour cells more susceptible to a unique form of cell death. This was discovered by researchers at the Rudolf Virchow Centre at the University of Würzburg.
more
A team from the Würzburg Institute of Experimental Biomedicine I and the Rudolf Virchow Center (RVZ) has fundamentally changed our understanding of platelet biology with a study published in the journal Science.
more
Five professors from the University of Würzburg are among the Highly Cited Researchers 2025. This list includes researchers whose work is cited particularly often by other scientists.
more
Dr. Hariharan Moorthy is investigating a special form of cell death that could enable innovative cancer therapies. An Alexander von Humboldt Fellowship allows him to conduct his research at the University of Würzburg.
more